Ultrasound can identify COVID-19 in pregnant women | Students develop COVID-19 fact sheets in 37 languages | Preeclampsia tied to neurologic risk in offspring
April 2, 2020
ACNM SmartBrief
News for nurse-midwives and women's health professionalsSIGN UP ⋅   SHARE
 
Maternal Health
Lung ultrasounds can be used to determine pregnant women in the early stages of COVID-19 and those with false-negative polymerase chain reaction test results, with scans proceeding from the basal to the upper thorax zones, according to a report in Ultrasound in Obstetrics & Gynecology. Any ultrasound machine can be used, but handheld scanners are best to avoid disease transmission, researchers wrote, while ultrasound focus settings should be adjusted to ensure an adequate pleural line view, and the gain should be reduced to emphasize A- and B-lines, as well as other hyperechoic indications.
Full Story: AuntMinnie (free registration) (4/1) 
LinkedIn Twitter Facebook Email
More than 175 medical school students led by first-year Harvard University Medical School student Pooja Chandrashekar are developing evidence-based COVID-19 treatment and prevention fact sheets in 37 languages, including fact sheets specifically for children and pregnant women. Though the CDC and some state health departments have made information available in languages other than English, the COVID-19 Health Literacy Project aims to fill gaps and function as a "centralized repository of information," Chandrashekar says.
Full Story: STAT (tiered subscription model) (4/1) 
LinkedIn Twitter Facebook Email
Researchers evaluated over 980,500 Norwegian children born at term and found that babies born to mothers who were preeclamptic had higher odds of developing intellectual disability, epilepsy, autism spectrum disorder and attention-deficit/hyperactivity disorder, as well as a slightly higher risk of developing hearing or vision loss, compared with those whose mothers had no preeclampsia. The findings, published online in JAMA Psychiatry, also showed that those who were exposed to preeclampsia had a lower mean gestational age at 39.3 weeks and had a lower average birth weight of 3,463 grams, compared with 39.8 weeks and 3,628 grams among babies with no exposure.
Full Story: MedPage Today (free registration) (4/1) 
LinkedIn Twitter Facebook Email
The FDA has given 510(k) clearance to Israel-based Nuvo Group for its INVU, a prenatal wearable sensor that tracks and collects data on the heart rate of the mother and fetus.
Full Story: MedCity News (3/31) 
LinkedIn Twitter Facebook Email
Women's Health & Primary Care
US coronavirus deaths top 5K, cases surpass 216K
San Francisco (Justin Sullivan/Getty Images)
Data from Johns Hopkins University showed the number of confirmed coronavirus cases in the US has risen beyond 216,000, and there have been more than 5,100 COVID-19-related fatalities, prompting Florida, Georgia and Mississippi to issue stay-at-home orders. Twelve states have not issued stay-at-home orders, and President Donald Trump declined to issue a nationwide stay-at-home order.
Full Story: CNBC (4/2),  CNN (4/2),  The Hill (4/1) 
LinkedIn Twitter Facebook Email
Women in early to middle adulthood who consistently slept seven to eight hours a night had a lower risk of developing type 2 diabetes later in life, compared to women of the same age group with persistent shorter sleep duration, according to a study published in Diabetes Care. However, these associations were weaker after adjustments for obesity and metabolic comorbidities, based on the analysis of data from 60,068 women without diabetes, cardiovascular disease or cancer.
Full Story: Physician's Briefing/HealthDay News (3/30) 
LinkedIn Twitter Facebook Email
Data from 121 clinical trials found that 14 popular diets led to some modest weight loss and improvements in blood pressure at six months for people with overweight or obesity, but by 12 months the effects had decreased to negligible, researchers reported in The BMJ. The top three diets for weight loss and BP reduction at six months were Atkins, Zone and DASH.
Full Story: MedPage Today (free registration) (4/1) 
LinkedIn Twitter Facebook Email
Infant Health
A study in JAMA Pediatrics of 33 neonates born to mothers testing positive for COVID-19 found three males of the 33 presented with the SARS-CoV-2 infection. All three experienced mild symptoms such as shortness of breath, and the most seriously ill infant's symptoms may have been related to premature birth, sepsis and asphyxia.
Full Story: Medscape (free registration) (3/27) 
LinkedIn Twitter Facebook Email
Children who had started eating solid foods at or before three months had a significantly higher bacteria diversity in their stool samples at three months and at 12 months, an indication of a more diverse gut bacterial population, compared with those who had started on solid foods at a later time, according to a study published in BMC Microbiology. The findings, based on data involving 67 children, also showed that infants who had started on solid foods by three months had significantly higher concentrations of butyric acid and total short-chain fatty acids at 12 months, which have been linked to an increased risk for obesity and diabetes.
Full Story: Futurity (4/1) 
LinkedIn Twitter Facebook Email
SmartBrief Originals
Sponsored content brought to you by SmartBrief
Professional News
Focus on what can be controlled, take time to reflect and breathe, express gratitude for simple things, and prioritize time for yourself. These are among the tips for self-care offered to health care workers feeling stress at work and home during the COVID-19 pandemic by Janie Heath, dean of the University of Kentucky College of Nursing, and Gwen Moreland, chief nurse executive for UK HealthCare.
Full Story: The Lane Report (Lexington, Ky.) (3/30) 
LinkedIn Twitter Facebook Email
Don't be afraid of what you want. This is your time. The barriers are down.
Morgan Freeman,
actor, narrator
LinkedIn Twitter Facebook Email
 
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
CONTACT US: FEEDBACK  |    ADVERTISE
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004